Evidence map›Paper›PMID 34198418›Full record

ArticleMathematical biosciences and engineering : MBE2021

Projecting the number of new HIV infections to formulate the "Getting to Zero" strategy in Illinois, USA.

Aditya Subhash Khanna, Mert Edali, Jonathan Ozik, Nicholson Collier, Anna Hotton, Abigail Skwara, Babak Mahdavi Ardestani, Russell Brewer, Kayo Fujimoto, Nina Harawa and 1 more

Open access · goldAbstract read
In one paragraph

Article in Mathematical biosciences and engineering : MBE, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. A Review of Network Models for HIV Spread.Journal of acquired immune deficiency syndromes (1999) · 2025
    Pooled it
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Aditya Subhash KhannaCenter for Alcohol and Addiction Studies, Brown University, Providence RI, USA.
Mert EdaliChicago Center for HIV Elimination, The University of Chicago, Chicago, IL, USA.
Jonathan OzikDecision and Infrastructure Sciences Division, Argonne National Laboratory, Lemont, IL, USA.
Nicholson CollierDecision and Infrastructure Sciences Division, Argonne National Laboratory, Lemont, IL, USA.
Anna HottonChicago Center for HIV Elimination, The University of Chicago, Chicago, IL, USA.
Abigail SkwaraChicago Center for HIV Elimination, The University of Chicago, Chicago, IL, USA.
Babak Mahdavi ArdestaniChicago Center for HIV Elimination, The University of Chicago, Chicago, IL, USA.
Russell BrewerChicago Center for HIV Elimination, The University of Chicago, Chicago, IL, USA.
Kayo FujimotoCenter for Health Promotion and Prevention Research, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.
Nina HarawaDepartment of Psychiatry and Human Behavior, Charles R. Drew University, Los Angeles, CA, USA.
John A SchneiderChicago Center for HIV Elimination, The University of Chicago, Chicago, IL, USA.
University of Chicago · USArgonne National Laboratory · USBrown University · USCharles R. Drew University of Medicine and Science · USThe University of Texas Health Science Center at Houston · US

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RAPHAEL J LANDOVITZ · 1997 to 2026
$53.5M
Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI LARRY K BROWN · 1998 to 2026
$51.7M
Virology and Immunology Technology CoreP30AI117943 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Michael E Newcomb · 2015 to 2026
$38.4M
INNOVATIVE IMPLEMENTATION RESEARCH METHODS COREP30DA027828 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BROWN, C. HENDRICKS, MUSTANSKI, BRIAN · 2011 to 2020
$11.4M
Training Program for Scientists Conducting Research to Reduce HIV Health DisparitR25MH067127 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Emily A Arnold, Torsten Brian Neilands · 2003 to 2026
$5.4M
HIV intervention models for criminal justice involved substance-using Black MSMR01DA039934 · NIDA · UNIVERSITY OF CHICAGO · PI FUJIMOTO, KAYO, HARAWA, NINA THAWATA · 2015 to 2019
$3.6M
MODELING COMBINATION BIOMEDICAL SUBSTANCE USE INTERVENTIONS TO INFORM A GETTING TO ZERO IMPLEMENTATION FOR BLACK MEN WHO HAVE SEX WITH MENR03DA049662 · NIDA · UNIVERSITY OF CHICAGO · PI KHANNA, ADITYA SUBHASH · 2019 to 2020
$162k
NIAID NIH HHS P30 AI042853NIAID NIH HHS P30 AI117943NIDA NIH HHS P30 DA027828NIDA NIH HHS R01 DA039934NIDA NIH HHS R03 DA049662NIMH NIH HHS P30 MH058107NIMH NIH HHS R25 MH067127
6 · The paper itself

Abstract

objectivesGetting to Zero (GTZ) initiatives focus on expanding use of antiretroviral treatment (ART) and pre-exposure prophylaxis (PrEP) to eliminate new HIV infections. Computational models help inform policies for implementation of ART and PrEP continuums. Such models, however, vary in their design, and may yield inconsistent predictions. Using multiple approaches can help assess the consistency in results obtained from varied modeling frameworks, and can inform optimal implementation strategies.

methodsA study using three different modeling approaches is conducted. Two approaches use statistical time series analysis techniques that incorporate temporal HIV incidence data. A third approach uses stochastic stimulation, conducted using an agent-based network model (ABNM). All three approaches are used to project HIV incidence among a key population, young Black MSM (YBMSM), over the course of the GTZ implementation period (2016-2030).

resultsAll three approaches suggest that simultaneously increasing PrEP and ART uptake is likely to be more effective than increasing only one, but increasing ART and PrEP by 20% points may not eliminate new HIV infections among YBMSM. The results further suggest that a 20% increase in ART is likely to be more effective than a 20% increase in PrEP. All three methods consistently project that increasing ART and PrEP by 30% simultaneously can help reach GTZ goals.

conclusionsIncreasing PrEP and ART uptake by about 30% might be necessary to accomplish GTZ goals. Such scale-up may require addressing psychosocial and structural barriers to engagement in HIV and PrEP care continuums. ABNMs and other flexible modeling approaches can be extended to examine specific interventions that address these barriers and may provide important data to guide the successful intervention implementation.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisHomosexuality, MaleHumansIllinoisMaleAnti-HIV Agentscomputer simulationHIV infectionspre-exposure prophylaxispreventive medicinesexual and gender minorities

Identifiers

PMID34198418
PMCPMC8281377
OpenAlexW3157124583

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.